<DOC>
	<DOCNO>NCT01728467</DOCNO>
	<brief_summary>This study build data high-density lipoprotein ( HDL ) number potentially beneficial effect include directly modulate glucose metabolism multiple mechanism . The primary objective study determine effect RVX000222 postprandial plasma glucose male individual impair fast glucose ( IFG ) impair glucose tolerance ( IGT ) , frequently sample oral glucose tolerance test ( OGTT ) .</brief_summary>
	<brief_title>The Effects RVX000222 Glucose Metabolism Individuals With Pre-diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Males age 1870 year , inclusive Body mass index ( BMI ) : 2540 kg/m2 HDL cholesterol plasma level : ≤1.4 mmol/L Prediabetes : Either impair fast glucose ( IFG ; 6.16.9mmol/L ) impair glucose tolerance ( IGT ; 2 hour OGTT glucose 7.811.0mmol/L , WHO classification ) measure Visit 1 No current use need prescription overthecounter medication within four day Visit 1 Have give sign informed consent participate study Identification medical condition require immediate therapeutic intervention Has receive overthecounter medication include vitamin , herbal , dietary supplement within four day Visit 1 unless prior approval Investigator Tobacco use within six month Visit 1 ( include cigarette , pipe , chew tobacco ) Elective surgery require general anaesthesia course study Clinically significant heart disease Visit 1 Clinically significant abnormal ECG Visit 1 Evidence renal impairment define serum creatinine &gt; 1.5 mg/dL ( 133 μmol/L ) creatinine clearance &lt; 60 mL/min History hypertension supine SBP &gt; 160mmHg DBP &gt; 95mmHg measure Visit 1 Evidence type 2 diabetes ( fast plasma glucose ≥7.0mmol/L ; 2 hour OGTT glucose ≥11.1mmol/L ) Evidence liver disease define aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) total bilirubin &gt; 1.5 x upper limit normal ( ULN ) Visit 1 History malignancy within past 5 year History evidence drug alcohol abuse within 12 month Visit 1 Use investigational drug and/or device time enrolment , within 30 day Visit 1 History noncompliance medical regimen unwillingness comply study protocol Any condition opinion Investigators would confound evaluation interpretation data Persons directly involved execution protocol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>